Séminaire

Lundi 22 Avril 2024

11h

Hôpital site de Paris - Amphithéâtre Constant-Burg - 12 rue Lhomond, Paris 5e

Microenvironmental coordination in the control of human cancers

My lab is dedicated to discovering how the immune system controls cancer and how it can be harnessed for therapeutic purposes. Our work has helped identify how certain cancers are regulated by various immune cells, including cytotoxic T-cells, regulatory T-cells, macrophages, monocytes, neutrophils and dendritic cells, all of which are considered drug targets in cancer immunotherapy. Here I will talk about the coordination of microenvironmental (immune) components that control human cancers.

Orateur(s)

Mikael Pittet
Professor of Immunology

Faculty of Medicine, University of Geneva, Full Member, Ludwig Institute for Cancer Research, Geneva University Hospitals (HUG) & Swiss Cancer Center Leman (SCCL)

Invité(e)(s) par

Lennon Ana Maria

Institut Curie

Eliane Piaggio

Institut Curie

Contact

Sylvia Trival

En bref

Pittet lab:

Our goal is to acquire missing knowledge to find better ways to fight cancer. Our areas of expertise are immunology and immunotherapy. We are part of the Department of Pathology and Immunology at the University of Geneva, and are physically located in the AGORA Cancer Research Center in Lausanne. Our work has identified how certain cancers are regulated by various immune cells, including cytotoxic T cells, regulatory T cells, macrophages, monocytes, neutrophils and dendritic cells, all of which are considered drug targets in cancer immunotherapy. We are also using a variety of approaches, including intravital imaging, to better understand how drugs targeting components of the immune system work in vivo, and how these treatments could be improved rationally to be effective against a wider range of tumors and in more patients. ...

En savoir plus

https://agora-cancer.ch/laboratory/pittet-lab/